Prediction and cost-effectiveness comparison of amblyopia screening methods at ages 3-4years

Sandra Viegas Guimaraes1,2, Paula Alexandra Veiga3, Patrício Soares Costa4,5

  • 1FP-I3ID (Instituto de Investigação, Inovação e Desenvolvimento da UFP)/HE-UFP (Hospital-Escola da UFP).

Insights

Combining uncorrected visual acuity (UCVA) and Plusoptix (PO) measurements is the most cost-effective strategy for amblyopia screening in young children. This combined approach significantly reduces costs per treated child while maintaining high sensitivity for early detection.

Area of Science:

  • Ophthalmology
  • Pediatric Health
  • Public Health Screening

Background:

  • Amblyopia, or 'lazy eye,' is a leading cause of preventable vision impairment in children.
  • Early detection and intervention are crucial for effective amblyopia treatment.
  • Current screening methods vary in performance and cost-effectiveness.

Purpose of the Study:

  • To compare the diagnostic performance and cost-effectiveness of different amblyopia screening test combinations.
  • To develop optimal screening strategies for early amblyopia detection in children.

Main Methods:

  • Exploratory factor analyses (EFA) of screening tests including uncorrected visual acuity (UCVA), Plusoptix (PO), Randot Stereo-test (SR), and Cover-Test (CT) in 3295 children.
  • Receiver Operating Characteristic (ROC) curves and confusion matrices were used to evaluate model prediction accuracy.
  • Cost-effectiveness analysis was performed for different screening strategies.

Main Results:

  • Models incorporating PO or UCVA demonstrated superior prediction capacity (R² > 0.4) and discriminating ability (AUC > 0.95) for amblyopia.
  • The combination of UCVA + PO achieved 96% sensitivity and was the most cost-effective strategy, with significantly lower costs per treated child compared to using either test alone.
  • Adding SR to UCVA or PO offered cost savings of 28% and 18%, respectively, when the UCVA + PO combination was not feasible.

Conclusions:

  • Simultaneous screening with UCVA and PO is recommended for young children (3-4 years) due to its superior cost-effectiveness and high sensitivity in detecting amblyopia.
  • The perceived increase in examination time for combined UCVA + PO screening is offset by substantial cost reductions per treated child.
  • Cover-Test (CT) showed no benefit in screening settings with good primary care, and the Randot Stereo-test (SR) provided limited added value.
Abstract

Related Concept Videos